Publications by authors named "Giulia Perrone"

Claim this Profile
S
Sequence/structural/functional relationships between Ganoderma fungal immunomodulatory proteins (gFIPs) and proteins involved in the modulation of immune response.
Nikola Schlosserová, Giulia Chiara Maria Perrone, Jakub Treml, Maria Noemi Sgobba, Lorenzo Guerra

J Struct Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Dimensional Modeling of T Cell Receptor Gamma (TRG)_Delta (TRD)/CD1D Complex Reveals Different Binding Interactions Depending on the TRD CDR3 Length.
Salvatrice Ciccarese, Marie-Paule Lefranc, Giulia C M Perrone, Pietro D'Addabbo, Ciro Leonardo Pierri

Antibodies (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving access to care and community health in Haiti with optimized community health worker placement.
Clara Champagne, Andrew Sunil Rajkumar, Paul Auxila, Giulia Perrone, Marvin Plötz

PLOS Glob Public Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.
Matteo C Da Vià, Bachisio Ziccheddu, Akihiro Maeda, Filippo Bagnoli, Giulia Perrone

Hemasphere· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the sustainable development goals through human rights accountability reviews.
Judith Bueno de Mesquita, Rebekah Thomas, Camille Gauter, Alexandra Havkwist, Robert Hoddy, Giulia Perrone

Bull World Health Organ· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Enrica Borsi, Giulia Perrone, Carolina Terragna, Marina Martello, Elena Zamagni

Exp Cell Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.
Vittorio Montefusco, Monica Galli, Francesco Spina, Paola Stefanoni, Alberto Mussetti, Giulia Perrone

Leuk Lymphoma· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma.
Enrica Borsi, Giulia Perrone, Carolina Terragna, Marina Martello, Angela F Dico

Oncotarget· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.
Lucia Pantani, Elena Zamagni, Beatrice Anna Zannetti, Annalisa Pezzi, Paola Tacchetti, Giulia Perrone

Ann Hematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation for T-cell lymphomas.
Giulia Perrone, Paolo Corradini

Semin Hematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
Giulia Perrone, Lucia Farina, Paolo Corradini

Expert Rev Hematol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.
Cristina Nanni, Elena Zamagni, Monica Celli, Paola Caroli, Valentina Ambrosini, Giulia Perrone

Clin Nucl Med· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Michele Cavo, Lucia Pantani, Maria Teresa Petrucci, Francesca Patriarca, Elena Zamagni, Giulia Perrone

Blood· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma.
Elena Zamagni, Alessandro Petrucci, Patrizia Tosi, Paola Tacchetti, Giulia Perrone

Ann Hematol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Zannetti, Emanuela Englaro, Giulia Perrone

Blood· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.
Güllü Görgün, Elisabetta Calabrese, Ender Soydan, Teru Hideshima, Giulia Perrone

Blood· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Giulia Perrone, Naoya Miura

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency.
Patrizia Tosi, Elena Zamagni, Paola Tacchetti, Michela Ceccolini, Giulia Perrone

Biol Blood Marrow Transplant· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
Güllü Görgün, Elisabetta Calabrese, Teru Hideshima, Jeffrey Ecsedy, Giulia Perrone

Blood· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
Diana Cirstea, Teru Hideshima, Scott Rodig, Loredana Santo, Samantha Pozzi, Giulia Perrone

Mol Cancer Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
Michele Cavo, Francesco Di Raimondo, Elena Zamagni, Francesca Patriarca, Paola Tacchetti, Giulia Perrone

J Clin Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Robert J Lutz, Hiroshi Yasui, Giulia Perrone

Clin Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
Patrizia Tosi, Carolina Terragna, Nicoletta Testoni, Elena Zamagni, Matteo Renzulli, Giulia Perrone

Eur J Haematol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Elena Zamagni, Cristina Nanni, Francesca Patriarca, Emanuela Englaro, Paolo Castellucci, Giulia Perrone

Haematologica· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo, Giulia Perrone

Blood· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis